Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban.

Greg J. Marchand,Richard Blumrick,Alexandra D Ruuska,Kelly Ware,Ahmed Taher Masoud,Alexa King,Stacy Ruther,Giovanna Brazil,Kaitlynne Cieminski,Nicolas Calteux,Hollie Ulibarri,Katelyn Sainz

Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban.

2021

Greg J. Marchand
Richard Blumrick
Alexandra D Ruuska
Kelly Ware
Ahmed Taher Masoud
Alexa King
Stacy Ruther
Giovanna Brazil
Kaitlynne Cieminski
Nicolas Calteux
Hollie Ulibarri
Katelyn Sainz

To assess the efficacy, safety, and tolerability of retosiban—a novel tocolytic unavailable in the US—in the management of preterm labor.We searched ClinicalTrials.Gov, MEDLINE, PubMed, SCOPUS, Web...

Keywords:

Retosiban
Medicine
MEDLINE
Tolerability
Bioinformatics
preterm labor
Oxytocin receptor
Meta-analysis
Tocolytic
Scopus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations